Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Residency Update

30 Jan 2018 07:00

RNS Number : 2599D
Phoenix Group Holdings
30 January 2018
 

Phoenix Group Holdings

LEI: 21380031B1D56JRCE375

Notice to PGH shareholders and to holders of outstanding debt securities regarding change in the head office and tax residence of Phoenix Group Holdings ("PGH")

Further to the announcement dated 21 June 2017, notice is hereby given that with effect from 31 January 2018 the central management and control, and the head office, of PGH will move from Jersey to the United Kingdom, with the intention that PGH will be resident in the United Kingdom for tax purposes from such date.

With effect from 31 January 2018, the PRA will treat PGH, and not Phoenix Life Holdings Limited ("PLHL"), as the ultimate EEA insurance holding company of the Insurance Group.

Holders of the subordinated securities:

· £428,113,000 6.625 per cent. Guaranteed Subordinated Notes due 2025;

· £450,000,000 4.125 per cent. Tier 3 Notes due 2022 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme; and

· U.S.$500,000,000 5.375 per cent. Notes due 2027 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme,

each issued by PGH (together, the "Outstanding Subordinated Securities"), are hereby notified that as such, PGH will become the ultimate EEA insurance holding company and the Insurance Group Parent Entity and a member of the Insurance Group for the purposes of the terms and conditions of the Outstanding Subordinated Securities. This will result in the Outstanding Subordinated Securities (and not the relevant on-loan of the proceeds of the Outstanding Subordinated Securities) being the only relevant capital item for the purposes of the definition of "Capital Disqualification Event" under the Outstanding Subordinated Securities with effect from such date.

PLHL will no longer be required by the PRA to be taken into account for the purposes of the deferral of principal and interest on the Outstanding Subordinated Securities pursuant to the definitions of "Regulatory Deficiency Interest Deferral Event" and "Regulatory Deficiency Redemption Deferral Event".

Capitalised terms that are not defined in this announcement will have the meanings given to them in the terms and conditions of the Outstanding Subordinated Securities.

The change in tax residency is not expected to impact PGH shareholders, other than UK stamp duty reserve tax (currently levied at 0.5%) will be incurred on subsequent purchases of PGH depositary interests.

Any PGH shareholder who is uncertain of the implications of the change in PGH's tax residency on their investment is recommended to obtain professional advice.

The change in tax residency will not impact the terms and conditions of the £300,000,000 5.75 per cent. Bonds due 2021 (of which £121,610,000 remains outstanding).

For further information, please contact:

 

Debt investors:

Rashmin Shah, Group Treasurer, Phoenix Group

Telephone: +44 (0) 20 3735 0059

Email: rashmin.shah@thephoenixgroup.com

 

Equity investors/analysts:Sam Perowne, Head of Investor Relations, Phoenix GroupTelephone: +44 (0) 20 3735 0021

Email: Samuel.Perowne@thephoenixgroup.com

 

 

Website: www.thephoenixgroup.com

 

This notice does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEDFWUFASEDF
Date   Source Headline
7th Mar 20174:30 pmRNSDirector/PDMR Shareholding
28th Feb 20174:00 pmRNSTotal Voting Rights
16th Feb 20174:30 pmRNSDirector/PDMR Shareholding
8th Feb 20174:30 pmRNSDirector/PDMR Shareholding
10th Jan 20173:30 pmRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSTrading Update and Credit Investor Roadshow
5th Jan 20174:30 pmRNSDirector/PDMR Shareholding
30th Dec 201610:42 amRNSCompletion of the Abbey Life Acquisition
28th Dec 20164:00 pmRNSDirector/PDMR Shareholding
20th Dec 201612:30 pmRNSHolding(s) in Company
14th Dec 20165:15 pmRNSHolding(s) in Company
13th Dec 20164:30 pmRNSHolding(s) in Company
13th Dec 20163:00 pmRNSRegulatory Consent - Abbey Life Acquisition
7th Dec 20163:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20164:30 pmRNSDirector/PDMR Shareholding
30th Nov 20164:00 pmRNSTotal Voting Rights
30th Nov 20162:45 pmRNSDirectorate Change
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
23rd Nov 20164:45 pmRNSDirector/PDMR Shareholding
21st Nov 20165:00 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSHolding(s) in Company
11th Nov 20166:00 pmRNSDirector/PDMR Shareholding
11th Nov 201611:00 amRNSHolding(s) in Company
9th Nov 20165:13 pmRNSDirector/PDMR Shareholding
9th Nov 201612:00 pmRNSTotal Voting Rights
9th Nov 201611:30 amRNSResults of Rump Placing
9th Nov 20167:00 amRNSResults of Rights Issue
3rd Nov 20164:00 pmRNSDirector/PDMR Shareholding
1st Nov 20164:30 pmRNSDirector/PDMR Shareholding
1st Nov 20167:45 amRNSCompletion of the AXA Business Acquisition
31st Oct 20164:30 pmRNSDirector/PDMR Shareholding
31st Oct 20164:30 pmRNSTotal Voting Rights
28th Oct 20164:15 pmRNSDirector/PDMR Shareholding
27th Oct 20164:00 pmRNSDirector/PDMR Shareholding
25th Oct 20165:45 pmRNSHolding(s) in Company
25th Oct 20168:07 amRNSAdmission of Nil Paid Rights
24th Oct 201610:15 amRNSEGM Results Announcement
19th Oct 20164:30 pmRNSHolding(s) in Company
17th Oct 20165:30 pmRNSRegulatory Consent - AXA Business Acquisition
14th Oct 20164:30 pmRNSDirector/PDMR Shareholding
12th Oct 20164:00 pmRNSBlock listing Interim Review
7th Oct 20164:02 pmRNSDirector/PDMR Shareholding
5th Oct 201610:00 amRNSHolding(s) in Company
4th Oct 20165:41 pmRNSCircular and Prospectus Publication
4th Oct 201610:00 amRNSHolding(s) in Company
30th Sep 20164:05 pmRNSTotal Voting Rights
28th Sep 20168:00 amRNSProposed Acquisition of Abbey Life

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.